In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study
Abstract The impact of underlying immune-mediated inflammatory diseases (IMID) in patients undergoing hematopoietic stem cell transplant (HSCT) is unclear. Hematopoietic cell transplantation co-morbidity index (HCT-CI) is gaining acceptance as a reliable clinical method to score pre-transplant co-mo...
Main Authors: | Kathan Mehta, Palashkumar Jaiswal, Farren Briggs, William A. Faubion, James H. Tabibian, Fabio Cominelli, Maneesh Dave |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-018-24060-4 |
Similar Items
-
The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation
by: Lam T. Khuat, et al.
Published: (2021-01-01) -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
by: Silvia F Costa, et al.
Published: (2013-11-01) -
Bacteremia in pediatric patients with hematopoietic stem cell transplantation
by: Paola Perez, et al.
Published: (2020-01-01) -
Comment on: Bacteremia in pediatric patients with hematopoietic stem transplantation
by: Antonio Vaz de Macedo
Published: (2020-01-01) -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Murat Akova
Published: (2017-01-01)